تداخل‌های دارویی
Glimepiride + Insulin degludec-liraglutide
شدت: شدید
Glimepiride and Insulin degludec-liraglutide: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Combining a GLP-1 agonist and insulin with a sulfonylurea increases the risk of hypoglycemia, which can be severe. The risk is highest when the sulfonylurea dose is not reduced.
معنای این تداخل به زبان ساده
Glimepiride and Insulin degludec-liraglutide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Glimepiride belongs to Endocrine; Insulin degludec-liraglutide belongs to Endocrine.
چرا رخ می‌دهد
Additive stimulation of insulin secretion and insulin effect, producing synergistic glucose lowering.
اقدام لازم
Consider reducing the glimepiride dose, or stopping it, when this combination is started. Monitor glucose closely and educate the patient about hypoglycemia.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Glimepiride و Insulin degludec-liraglutide، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Insulin degludec-liraglutide
تداخلات دیگر Glimepiride
پرسش‌های متداول
Can I take Glimepiride with Insulin degludec-liraglutide?
MediHelp rates the interaction as major. Glimepiride and Insulin degludec-liraglutide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Combining a GLP-1 agonist and insulin with a sulfonylurea increases the risk of hypoglycemia, which can be severe. The risk is highest when the sulfonylurea dose is not reduced.
How serious is the interaction between Glimepiride and Insulin degludec-liraglutide?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider reducing the glimepiride dose, or stopping it, when this combination is started. Monitor glucose closely and educate the patient about hypoglycemia.
What other medicines interact with Insulin degludec-liraglutide?
MediHelp also lists interactions of Insulin degludec-liraglutide with, for example, Albiglutide, Chlorpropamide, Clozapine. The full list is on the Insulin degludec-liraglutide page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
